These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1199 related articles for article (PubMed ID: 12014625)

  • 1. Melanoma-inhibiting activity (MIA/CD-RAP) is expressed in a variety of malignant tumors of mainly neuroectodermal origin.
    Hau P; Apfel R; Wiese P; Tschertner I; Blesch A; Bogdahn U
    Anticancer Res; 2002; 22(2A):577-83. PubMed ID: 12014625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mouse CD-RAP/MIA gene: structure, chromosomal localization, and expression in cartilage and chondrosarcoma.
    Bosserhoff AK; Kondo S; Moser M; Dietz UH; Copeland NG; Gilbert DJ; Jenkins NA; Buettner R; Sandell LJ
    Dev Dyn; 1997 Apr; 208(4):516-25. PubMed ID: 9097023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of melanoma cells in the blood of melanoma patients by melanoma-inhibitory activity (MIA) reverse transcription-PCR.
    Mühlbauer M; Langenbach N; Stolz W; Hein R; Landthaler M; Buettner R; Bosserhoff AK
    Clin Cancer Res; 1999 May; 5(5):1099-105. PubMed ID: 10353744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melanoma-inhibiting activity, a novel serum marker for progression of malignant melanoma.
    Bosserhoff AK; Kaufmann M; Kaluza B; Bartke I; Zirngibl H; Hein R; Stolz W; Buettner R
    Cancer Res; 1997 Aug; 57(15):3149-53. PubMed ID: 9242442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In situ expression patterns of melanoma-inhibiting activity (MIA) in melanomas and breast cancers.
    Bosserhoff AK; Moser M; Hein R; Landthaler M; Buettner R
    J Pathol; 1999 Mar; 187(4):446-54. PubMed ID: 10398105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression levels of melanoma inhibitory activity correlate with time to progression in patients with high-grade glioma.
    Hau P; Ruemmele P; Kunz-Schughart LA; Doerfelt A; Hirschmann B; Lohmeier A; Koch H; Mueller A; Bogdahn U; Bosserhoff AK
    Oncol Rep; 2004 Dec; 12(6):1355-64. PubMed ID: 15547763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melanoma-inhibiting activity (MIA) mRNA is not exclusively transcribed in melanoma cells: low levels of MIA mRNA are present in various cell types and in peripheral blood.
    de Vries TJ; Fourkour A; Punt CJ; Diepstra H; Ruiter DJ; van Muijen GN
    Br J Cancer; 1999 Nov; 81(6):1066-70. PubMed ID: 10576666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cloning and characterization of the expression pattern of a novel splice product MIA (splice) of malignant melanoma-derived growth-inhibiting activity (MIA/CD-RAP) [corrected].
    Hau P; Wise P; Bosserhoff AK; Blesch A; Jachimczak P; Tschertner I; Bogdahn U; Apfel R
    J Invest Dermatol; 2002 Sep; 119(3):562-9. PubMed ID: 12230496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MIA, a novel serum marker for progression of malignant melanoma.
    Bosserhoff AK; Lederer M; Kaufmann M; Hein R; Stolz W; Apfel R; Bogdahn U; Buettner R
    Anticancer Res; 1999; 19(4A):2691-3. PubMed ID: 10470221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum cartilage-derived retinoic acid-sensitive protein (CD-RAP) levels in swarm rat chondrosarcoma.
    Yonekawa M; Kondo S; Sugiura H; Kobayashi K; Watanabe T; Kimata K; Sandell LJ; Iwata H
    J Orthop Res; 2002 Mar; 20(2):382-6. PubMed ID: 11918321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of S100 protein and MIA protein as serum marker for malignant melanoma.
    Djukanovic D; Hofmann U; Sucker A; Rittgen W; Schadendorf D
    Anticancer Res; 2000; 20(3B):2203-7. PubMed ID: 10928178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization and chromosomal assignment of equine cartilage derived retinoic acid sensitive protein (CD-RAP)/melanoma inhibitory activity (MIA).
    Berg LC; Mata X; Thomsen PD
    Gene; 2008 Jan; 407(1-2):98-104. PubMed ID: 17977671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional role of MIA in melanocytes and early development of melanoma.
    Poser I; Tatzel J; Kuphal S; Bosserhoff AK
    Oncogene; 2004 Aug; 23(36):6115-24. PubMed ID: 15208686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of melanoma inhibitory activity and other differentially expressed messenger RNAs in human melanoma cell lines with different metastatic capacity by messenger RNA differential display.
    van Groningen JJ; Bloemers HP; Swart GW
    Cancer Res; 1995 Dec; 55(24):6237-43. PubMed ID: 8521420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased expression of both the low-density lipoprotein receptor-related protein/alpha(2)-macroglobulin receptor and its receptor-associated protein in late stages of cutaneous melanocytic tumor progression.
    de Vries TJ; Verheijen JH; de Bart AC; Weidle UH; Ruiter DJ; van Muijen GN
    Cancer Res; 1996 Mar; 56(6):1432-9. PubMed ID: 8640836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of mesenchymal stem cell and chondrocyte differentiation by MIA.
    Tscheudschilsuren G; Bosserhoff AK; Schlegel J; Vollmer D; Anton A; Alt V; Schnettler R; Brandt J; Proetzel G
    Exp Cell Res; 2006 Jan; 312(1):63-72. PubMed ID: 16256983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of melanoma inhibitory activity (MIA) enhances extravasation and metastasis of A-mel 3 melanoma cells in vivo.
    Guba M; Bosserhoff AK; Steinbauer M; Abels C; Anthuber M; Buettner R; Jauch KW
    Br J Cancer; 2000 Nov; 83(9):1216-22. PubMed ID: 11027436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of Lerk-5/Eplg5 messenger RNA: a novel marker for increased tumorigenicity and metastatic potential in human malignant melanomas.
    Vogt T; Stolz W; Welsh J; Jung B; Kerbel RS; Kobayashi H; Landthaler M; McClelland M
    Clin Cancer Res; 1998 Mar; 4(3):791-7. PubMed ID: 9533549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p54nrb is a new regulator of progression of malignant melanoma.
    Schiffner S; Zimara N; Schmid R; Bosserhoff AK
    Carcinogenesis; 2011 Aug; 32(8):1176-82. PubMed ID: 21642354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated MIA serum levels are predictors of poor prognosis after surgical resection of metastatic malignant melanoma.
    Guba M; Steinbauer M; Ruhland V; Schütz A; Geissler EK; Anthuber M; Vogt T; Bosserhoff A; Jauch KW
    Oncol Rep; 2002; 9(5):981-4. PubMed ID: 12168059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 60.